Although previous studies reported various results, M2-like TAMs generally release immunosuppressive cytokines, transforming growth factor-beta, and vascular endothelial growth factor (VEGF), leading to tumor progression and drug resistance [15–17]. This evidence concerns the gene VEGFA and neoplasm.